Intracerebroventricularly-administered agonists of G protein-coupled receptor 17 (GPR17) stimulate and antagonists inhibit feeding, with the agonists promoting insulin resistance in response to high fat diet (3). The gene discussed is GPR17; the disease is Insulin resistance.